Department of Cardiology, Ondokuz Mayıs University Faculty of Medicine, Samsun, Türkiye.
Department of Cardiology, Çukurova University Faculty of Medicine, Adana, Türkiye.
Turk Kardiyol Dern Ars. 2023 Oct;51(7):516-520. doi: 10.5543/tkda.2023.52279.
Six-minute walk test (6MWT) is the most widely used exercise capacity measurement worldwide in patients with pulmonary hypertension (PH). Although cardiopulmonary exercise testing (CPET) is the gold standard for the assessment of exercise capacity in cardiovascular diseases; the limited accessibility of the device, the need for experience in interpreting the results, and the difficulties in performing CPET in advanced PH have aroused the interest in the application of easier methods for the measurement of exercise capacity. Since then, accumulated data proved that; 6-minutes walking distance (6MWD) can be used to determine exercise capacity and is highly correlated with maximum oxygen consumption (peak VO2) detected by CPET in patients with heart failure and/or PH. Moreover, 6MWT is very easy and practical to apply in all PH subgroups. This review is focused on the application of a reliable 6MWT and the interpretation of the results in patients with PH.
六分钟步行试验(6MWT)是目前全球范围内用于肺动脉高压(PH)患者运动能力评估的最广泛应用的方法。尽管心肺运动试验(CPET)是评估心血管疾病患者运动能力的金标准;但由于设备的有限可及性、对结果进行解释的经验需求以及在晚期 PH 中进行 CPET 的困难,促使人们对更易于应用的运动能力测量方法产生了兴趣。此后,积累的数据证明;6 分钟步行距离(6MWD)可用于确定运动能力,并且与心力衰竭和/或 PH 患者通过 CPET 检测到的最大耗氧量(峰值 VO2)高度相关。此外,6MWT 在所有 PH 亚组中都非常易于实施且实用。这篇综述重点介绍了在 PH 患者中可靠的 6MWT 的应用和结果解读。